What is it about?
Chronic airway diseases, such as asthma and chronic obstructive pulmonary disease (COPD), are highly heterogeneous and require individualized assessment and treatment, so-called precision medicine. This paper summarizes the discussions of an ERS Research Seminar held in Barcelona on February 21, 2017 on how to best apply precision medicine to asthma and COPD.
Featured Image
Read the Original
This page is a summary of: Precision medicine in airway diseases: moving to clinical practice, European Respiratory Journal, October 2017, European Respiratory Society (ERS),
DOI: 10.1183/13993003.01655-2017.
You can read the full text:
Contributors
The following have contributed to this page
